News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER launches second phase of adult observational study
Throughout this phase, RECOVER will continue to collect information from about 5,000 people for 2 years to build a deeper understanding of how Long COVID affects people over time.
Feature
169 Results
169 Results
RECOVER Representatives help inform Long COVID sleep research through empathy, expertise, and engagement
RECOVER Representatives use their lived experience and feedback from their communities to make recommendations that help make RECOVER-SLEEP trial participation simpler and more accessible.
Feature
Digital health data provide insights into Long COVID
The RECOVER Digital Health Program used wearable devices to monitor participants’ health data and understand how Long COVID affected their daily activities and sleep.
Feature
RECOVER Research Update: September 2025
Recent RECOVER research has revealed important links between Long COVID and a range of other physical, mental, and emotional health conditions.
Research Update
Registration open for second annual RECOVER-TLC workshop, September 9-10
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Announcement
RECOVER-ENERGIZE explores personalized program to help people with Long COVID regain physical activity
Leveraging staff expertise and consistent monitoring, a RECOVER-ENERGIZE clinical trial is exploring whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID regain physical activity.
Feature
Researchers invited to submit proposals for new round of ancillary pathobiology studies
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Feature
Electronic health record study examines how COVID-19 severity impacts risk of autoimmune diseases
Researchers found that severe COVID-19 can cause a strong immune response, which can cause the body’s immune system to attack itself and lead to new autoimmune diseases.
Feature
Researcher Spotlight: Shari B. Brosnahan, MD
Drawing on her experience working in intensive care, expertise in lung health, and knowledge of medical imaging, Dr. Brosnahan is leading studies that could inform the development of treatments for specific Long COVID symptoms.
Feature